Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1584)
  2. Meeting Abstract (783)
  3. Book Section (104)
  4. Review (68)
  5. Editorial (58)
  6. Research Letter (42)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1668)
  2. Survivorship Research (1183)
  3. Solid Tumor Oncology Division (1037)
  4. Department of Pathology and Laboratory Medicine (947)
  5. Surgery (939)
  6. Melanoma and Immunotherapeutics Service (783)

More Groups

People
  1. Klaus Busam (689)
  2. Daniel Coit (542)
  3. Allan Halpern (396)
  4. Michael Postow (362)
  5. Alexander Shoushtari (244)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (56)
  2. 2024 (136)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (264)
  2. Annals of Surgical Oncology (220)
  3. Journal of the American Academy of Dermatology (122)
  4. Journal of Investigative Dermatology (80)
  5. Modern Pathology (66)
  6. International Journal of Radiation Oncology, Biology, Physics (64)

More Publications

Publishers
  1. Springer (340)
  2. American Society of Clinical Oncology (279)
  3. Elsevier Inc. (227)
  4. Lippincott Williams & Wilkins (226)
  5. Wiley Blackwell (160)
  6. American Association for Cancer Research (157)

More Publishers

Results (2735)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports
    Meeting Abstract

    Chen, M. F.; Ma, W.; Caravella, B. A.; Harada, G.; Gangai, N.; Grimaldi, G.; Waksmundzki, A.; Trevenen, W.; Kohlasch, K.; Reynolds, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
    Meeting Abstract

    Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Signatures of early plasticity in the histological transformation of lung cancer
    Meeting Abstract

    Rakhade, S.; Chen, M. F.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Chaudhary, O.; Xu, T.; Masilionis, I.; Falcon, C. J.; Egger, J. V.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Acute care and overall survival results of a randomized trial of a virtual health intervention during routine cancer treatment
    Meeting Abstract

    Daly, R. M.; Bryl, K.; Baser, R. E.; Green, A.; Hung, T.; Gillespie, E. F.; Panageas, K.; Postow, M. A.; Mao, J. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Optimizing clinical research in a regional cancer center network: A survey-based approach
    Meeting Abstract

    Preeshagul, I. R.; Syldor, A.; Terzulli, S. L.; Gordon, R. A.; Evans, L. A.; Moran, S.; Eng, J.; Daly, R. M.; Rao, D.; Momtaz, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors
    Meeting Abstract

    Zhang, Z.; Gu, S.; Dusza, S.; Moy, A.; Dunkel, I.; Drilon, A.; Diamond, E.; Lacouture, M.; Markova, A.
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save